Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours

Por um escritor misterioso

Descrição

Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Antibodies, Free Full-Text
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Antibodies, Free Full-Text
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Construction and characterization of mAb–Ang2 conjugates. (A)
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
The Resurgence of Antibody Drug Conjugates in Cancer Therapeutics: Novel Targets and Payloads
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
The ever-expanding landscape of antibody-drug conjugates (ADCs) in solid tumors: A systematic review - ScienceDirect
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Cells, Free Full-Text
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Unlocking the potential of antibody–drug conjugates for cancer therapy
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Full article: Antibody drug conjugates for glioblastoma: current progress towards clinical use
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Antibody–drug conjugates for cancer - The Lancet
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Emerging new therapeutic antibody derivatives for cancer treatment
de por adulto (o preço varia de acordo com o tamanho do grupo)